Chun Huang

Dr. Chun Huang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2016 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
XWXiao-Wen Wang
Xiao-Wen Wang
CQCan Qu
Can Qu
CHChun Huang
Chun Huang
ZQZhi-Ming Qin
Zhi-Ming Qin
ZLZhi-Qian Lu
Zhi-Qian Lu
The clinical outcomes for left anterior descending (LAD) coronary artery lesion between minimally invasive direct coronary artery bypass (MIDCAB) and percutaneous coronary intervention (PCI) are still controversial. The objective was to compare safety and efficacy between MIDCAB and PCI for LAD. Electronic databases and article references were systematically searched to access relevant studies. End points included mortality, myocardial infarction, target vessel revascularization (TVR), major adverse coronary events (MACE), angina recurrence, and stroke. Fourteen studies with 941 patients were finally involved in the present study. The mortality and incidence of myocardial infarction were similar in MIDCAB and PCI groups at 30 days, 6 months, and at follow-up beyond 1 year. Compared with PCI, MIDCAB decreased incidence of TVR and MACE at 6 months and beyond 1 year follow-up. MIDCAB was associated with a lower incidence of angina recurrence at 6 months compared with PCI. PCI was associated with higher risk of restenosis in target vessel. No significant difference was shown for stroke. Our meta-analysis indicates that there are no significant differences in the safety between MIDCAB and PCI in patients with LAD. However MIDCAB is superior to PCI for TVR and MACE.

1 January 2017 in International Journal of Biological Sciences
Verified
Journal Article
Open access
XWXiao-Wen Wang
Xiao-Wen Wang
CZCheng Zhang
Cheng Zhang
KLKai-Chuen Lee
Kai-Chuen Lee
XHXiang-Jun He
Xiang-Jun He
ZLZhi-Qian Lu
Zhi-Qian Lu
QWQing-Chen Wu
Qing-Chen Wu
Background: Vein graft failure due to neointimal hyperplasia remains an important and unresolved complication of cardiovascular surgery. microRNA-21 (miR-21) plays a major role in regulating vascular smooth muscle cell (VSMC) proliferation and phenotype transformation. Thus, the purpose of this study was to determine whether adenovirus-mediated miR-21 sponge gene therapy was able to inhibit neointimal hyperplasia in rat vein grafts.

8 November 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XZXu Zhan
Xu Zhan
CZChang-Ming Zhong
Chang-Ming Zhong
HTHao Tang
Hao Tang
HXHansong Xiao
Hansong Xiao
YGYongzheng Guo
Yongzheng Guo
CHChun Huang
Chun Huang